ASC

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Talis, Talkspace, eHealth, and Oak Street and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, February 24, 2022

The complaint filed in this class action alleges that the Registration Statement was false and misleading and omitted to state material adverse facts.

Key Points: 
  • The complaint filed in this class action alleges that the Registration Statement was false and misleading and omitted to state material adverse facts.
  • For more information on the Talkspace class action go to: https://bespc.com/cases/TALK
    eHealth is a health insurance broker that focuses on selling Medicare-related policies on behalf of private insurers.
  • Its main source of revenue is commissions from selling Medicare Advantage, Medicare Supplement, and Medicare Part D prescription drug policies.
  • For more information on the Oak Street Health class action go to: https://bespc.com/cases/OSH
    About Bragar Eagel & Squire, P.C.

Global Aspiration & Biopsy Needles Market 2022-2027: Industry Trends, Regulatory Analysis, Competition Landscape, Leading Player Profiles - ResearchAndMarkets.com

Retrieved on: 
Wednesday, February 23, 2022

The global aspiration and biopsy needles market is valued at an estimated USD 879 million in 2021 and is projected to reach USD 1,303 million by 2027, at a CAGR of 6.8%.

Key Points: 
  • The global aspiration and biopsy needles market is valued at an estimated USD 879 million in 2021 and is projected to reach USD 1,303 million by 2027, at a CAGR of 6.8%.
  • On the basis of product, the aspiration and biopsy needles market is segmented into biopsy and aspiration needles.
  • On the basis of end-user, the aspiration and biopsy needles market is segmented into hospitals & surgical centres, ambulatory care centres, diagnostic clinics & pathology laboratories, and research & academic institutes.
  • The breast cancer segment accounted for the largest share of the aspiration and biopsy needles market in 2020.

Accounting Today names LeaseCrunch Verify a top new product of 2022

Retrieved on: 
Wednesday, February 23, 2022

MILWAUKEE, Wis., Feb. 23, 2022 /PRNewswire/ -- LeaseCrunch, a cloud-based lease accounting software company, announced LeaseCrunch Verify is a top new product of 2022, as named by Accounting Today.

Key Points: 
  • MILWAUKEE, Wis., Feb. 23, 2022 /PRNewswire/ -- LeaseCrunch, a cloud-based lease accounting software company, announced LeaseCrunch Verify is a top new product of 2022, as named by Accounting Today.
  • "We are honored that Accounting Today recognized LeaseCrunch Verify as a top product," said Ane Ohm, LeaseCrunch CEO.
  • "LeaseCrunch Verify provides firms with a simple tool that allows them to audit their clients' lease accounting in an efficient, transparent and cost-effective way.
  • This is the second time LeaseCrunch has had a product named a top new product by Accounting Today.

Pomerantz Law Firm Notifies Investors of eHealth, Inc. of a Pending Lawsuit and Lead Plaintiff Deadline of March 18, 2022

Retrieved on: 
Wednesday, February 23, 2022

NEW YORK, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP notifies investors of eHealth, Inc. (NASDAQ: EHTH) (eHealth or the Company) of a pending lawsuit against eHealth and certain of its officers.

Key Points: 
  • NEW YORK, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP notifies investors of eHealth, Inc. (NASDAQ: EHTH) (eHealth or the Company) of a pending lawsuit against eHealth and certain of its officers.
  • If you are a shareholder who purchased eHealth stock during the Class Period, you have until March 18, 2022 to ask the Court to appoint you as Lead Plaintiff for the class.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Its main source of revenue is commissions from selling Medicare Advantage, Medicare Supplement, and Medicare Part D prescription drug policies.

Cincinnati Welcomes a New Spine and Orthopaedic Practice: Grand Opening of BEST Surgery & Therapies

Retrieved on: 
Tuesday, February 22, 2022

CINCINNATI, Feb. 22, 2022 (GLOBE NEWSWIRE) -- BEST Surgery & Therapies is pleased to announce the grand opening of its new ambulatory surgery center located in Cincinnati, Ohio, on March 3, 2022.

Key Points: 
  • CINCINNATI, Feb. 22, 2022 (GLOBE NEWSWIRE) -- BEST Surgery & Therapies is pleased to announce the grand opening of its new ambulatory surgery center located in Cincinnati, Ohio, on March 3, 2022.
  • BEST Surgery & Therapies brings minimally invasive spine surgery, the latest conservative treatment, and surgical technology for spine & orthopaedic care to the Cincinnati area.
  • "BEST Surgery & Therapies is a practice with board-certified and fellowship-trained surgeons who specialize in minimally invasive spine surgery and so much more.
  • Established in 2020, BEST Surgery & Therapies provides premier leaders in state-of-the-art, minimally invasive orthopaedic and spine treatment and surgery.

Guillermo del Toro to Receive 1st Ever Gene Kelly Visionary Award

Retrieved on: 
Tuesday, February 22, 2022

The Advanced Imaging Society announced today that Academy Award-winning director and producer Guillermo del Toro will be honored with the first ever Gene Kelly Visionary Award at the 2022 AIS Lumiere Awards.

Key Points: 
  • The Advanced Imaging Society announced today that Academy Award-winning director and producer Guillermo del Toro will be honored with the first ever Gene Kelly Visionary Award at the 2022 AIS Lumiere Awards.
  • Guillermo del Toro fully embodies this same pioneering spirit, and we are thrilled he will be our first recipient.
  • Presenting the award to del Toro will be Kellys widow and biographer Patricia Ward Kelly.
  • I am deeply honored that he will be the first to receive the Gene Kelly Visionary Award.

Bragar Eagel & Squire, P.C. Is Investigating ReneSola, TaskUs, Tecnoglass, and WeWork and Encourages Investors to Contact the Firm

Retrieved on: 
Tuesday, February 22, 2022

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • The investigation focuses on ReneSolas statements about its purported development, construction, operation, and sales of solar power projects in Europe.
  • Accordingly, WeWork advised that certain of its previously issued financial statements should not be relied upon and would be restated.
  • For more information on the WeWork investigation go to: https://bespc.com/cases/WE
    About Bragar Eagel & Squire, P.C.

BURNHAM HOLDINGS, INC. ANNOUNCES YEAR 2021 FINANCIAL RESULTS AND EXECUTIVE LEADERSHIP RETIREMENT

Retrieved on: 
Thursday, February 17, 2022

Common stock outstanding at December 31, 2021 includes 3,257,971 of Class A shares and 1,329,298 of Class B shares.

Key Points: 
  • Common stock outstanding at December 31, 2021 includes 3,257,971 of Class A shares and 1,329,298 of Class B shares.
  • This note has beenexpanded to include items discussed in detail within the 2021 Annual Report.
  • The accompanying unaudited financial statements contain alladjustments that are necessary for a fair presentation of results for such periods and are consistent with policies and procedures employed in the audited year-end financial statements.
  • These consolidated financial statements should be read in conjunction with the Annual Report for the period ended December 31, 2021.

Pomerantz Law Firm Notifies Investors of eHealth, Inc. of a Pending Lawsuit and Lead Plaintiff Deadline of March 18, 2022

Retrieved on: 
Thursday, February 17, 2022

NEW YORK, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP notifies investors of eHealth, Inc. (NASDAQ: EHTH) (eHealth or the Company) of a pending lawsuit against eHealth and certain of its officers.

Key Points: 
  • NEW YORK, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP notifies investors of eHealth, Inc. (NASDAQ: EHTH) (eHealth or the Company) of a pending lawsuit against eHealth and certain of its officers.
  • If you are a shareholder who purchased eHealth stock during the Class Period, you have until March 18, 2022 to ask the Court to appoint you as Lead Plaintiff for the class.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Its main source of revenue is commissions from selling Medicare Advantage, Medicare Supplement, and Medicare Part D prescription drug policies.

Bragar Eagel & Squire, P.C. Is Investigating ReneSola, TaskUs, Tecnoglass, and WeWork and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, February 17, 2022

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • The investigation focuses on ReneSolas statements about its purported development, construction, operation, and sales of solar power projects in Europe.
  • Accordingly, WeWork advised that certain of its previously issued financial statements should not be relied upon and would be restated.
  • For more information on the WeWork investigation go to: https://bespc.com/cases/WE
    About Bragar Eagel & Squire, P.C.